| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Friedrich Koch-Nolte | Q37377538 |
| Bernhard Lüscher | Q38325972 | ||
| Michael O Hottiger | Q40388335 | ||
| Herwig Schüler | Q28320431 | ||
| P2093 | author name string | Paul O Hassa | |
| P433 | issue | 4 | |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 208-219 | |
| P577 | publication date | 2010-01-26 | |
| P1433 | published in | Trends in Biochemical Sciences | Q1565711 |
| P1476 | title | Toward a unified nomenclature for mammalian ADP-ribosyltransferases | |
| P478 | volume | 35 |
| Q24307446 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation |
| Q40774556 | 5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme |
| Q97681358 | A FRET-based high-throughput screening platform for the discovery of chemical probes targeting the scaffolding functions of human tankyrases |
| Q64115893 | A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation |
| Q38780396 | A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy. |
| Q37968558 | A decade of the human genome sequence--how does the medicinal chemist benefit? |
| Q52656406 | A small-molecule protein-protein interaction inhibitor of PARP1 that targets its BRCT domain. |
| Q37130712 | A systematic analysis of the PARP protein family identifies new functions critical for cell physiology. |
| Q34023226 | ADP-ribosylation of arginine |
| Q37855198 | ADP-ribosylation of histones by ARTD1: an additional module of the histone code? |
| Q64106175 | ADP-ribosylation signalling and human disease |
| Q39224361 | ADP-ribosylation: new facets of an ancient modification. |
| Q28595102 | ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence |
| Q34044292 | ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells |
| Q28082350 | ADP-ribosyltransferases and poly ADP-ribosylation |
| Q37556937 | ADPriboDB: The database of ADP-ribosylated proteins. |
| Q51746429 | ARTC1-mediated ADP-ribosylation of GRP78/BiP: a new player in endoplasmic-reticulum stress responses. |
| Q27027461 | ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death |
| Q34883050 | ARTD1-induced poly-ADP-ribose formation enhances PPARγ ligand binding and co-factor exchange |
| Q34254806 | ARTD1/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion. |
| Q39876937 | ARTD10 substrate identification on protein microarrays: regulation of GSK3β by mono-ADP-ribosylation. |
| Q37734336 | ARTD2 activity is stimulated by RNA. |
| Q38722174 | ATM induces MacroD2 nuclear export upon DNA damage |
| Q27323759 | Aag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1 |
| Q37861900 | Actin as target for modification by bacterial protein toxins |
| Q41791632 | Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. |
| Q91859979 | An Advanced Strategy for Comprehensive Profiling of ADP-ribosylation Sites Using Mass Spectrometry-based Proteomics |
| Q26770154 | An Overview of Chromatin-Regulating Proteins in Cells |
| Q35142718 | An update on PARP inhibitors for the treatment of cancer |
| Q38722995 | Apoptotic effects of bovine apo-lactoferrin on HeLa tumor cells |
| Q27676140 | Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex |
| Q37048317 | Aryl hydrocarbon receptor activation by dioxin targets phosphoenolpyruvate carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP-ribose) polymerase (TiPARP). |
| Q38997390 | Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling. |
| Q42909779 | Association of common SNP rs1136410 in PARP1 gene with the susceptibility to male infertility with oligospermia |
| Q52372449 | Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach. |
| Q41005662 | At the Interface of Three Nucleic Acids: The Role of RNA-Binding Proteins and Poly(ADP-ribose) in DNA Repair |
| Q24305535 | BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8 |
| Q38089268 | Beyond DNA repair, the immunological role of PARP-1 and its siblings. |
| Q53140423 | Bioorthogonally Functionalized NAD(+) Analogues for In-Cell Visualization of Poly(ADP-Ribose) Formation. |
| Q89664201 | Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3 Macrodomain Affect Neurovirulence in Mice |
| Q53037261 | Chain-terminating and clickable NAD⁺ analogues for labeling the target proteins of ADP-ribosyltransferases. |
| Q47800832 | Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation. |
| Q58100986 | Characterization of TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP/ARTD14) Catalytic Activity |
| Q38290704 | Characterization of the DNA dependent activation of human ARTD2/PARP2. |
| Q91935480 | Circular RNA TLK1 Aggravates Neuronal Injury and Neurological Deficits after Ischemic Stroke via miR-335-3p/TIPARP |
| Q89216503 | Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines |
| Q38931721 | Comparative Studies of Actin- and Rho-Specific ADP-Ribosylating Toxins: Insight from Structural Biology. |
| Q95300744 | Comparative analysis of MACROD1, MACROD2 and TARG1 expression, localisation and interactome |
| Q54940157 | Comparative inhibitory profile and distribution of bacterial PARPs, using Clostridioides difficile CD160 PARP as a model. |
| Q34026322 | Compartmentation of NAD+-dependent signalling. |
| Q28083849 | Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes |
| Q36561147 | Crosstalk between SET7/9-dependent methylation and ARTD1-mediated ADP-ribosylation of histone H1.4. |
| Q36913813 | Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes |
| Q27679467 | Crystal Structure of Human ADP-ribose Transferase ARTD15/PARP16 Reveals a Novel Putative Regulatory Domain |
| Q90724277 | Crystal Structure-Based Exploration of Arginine-Containing Peptide Binding in the ADP-Ribosyltransferase Domain of the Type III Effector XopAI Protein |
| Q27681466 | Crystallographic and biochemical analysis of the mouse poly(ADP-ribose) glycohydrolase |
| Q37643441 | DNA repair pathways in trypanosomatids: from DNA repair to drug resistance. |
| Q33805578 | DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells |
| Q92354414 | Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3 |
| Q27681720 | Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3- b ]pyridazin-8-amine Derivatives as Tankyrase Inhibitors |
| Q27684311 | Discovery and Structure–Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2 H )-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors |
| Q41846529 | Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG). |
| Q93166709 | Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515 |
| Q52642106 | Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2. |
| Q51071963 | Discovery of new dual binding TNKS inhibitors of Wnt signaling inhibition by pharmacophore modeling, molecular docking and bioassay. |
| Q41817338 | Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life |
| Q36430648 | Dynamic subcellular localization of the mono-ADP-ribosyltransferase ARTD10 and interaction with the ubiquitin receptor p62. |
| Q28383252 | Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism |
| Q39608823 | ENPP1 processes protein ADP-ribosylation in vitro. |
| Q47140669 | Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia |
| Q64104519 | Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation |
| Q46125090 | Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD+ Analogue. |
| Q41153612 | Engineering the substrate specificity of ADP-ribosyltransferases for identifying direct protein targets |
| Q26768267 | Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors |
| Q26745956 | Evaluation of the methods to identify patients who may benefit from PARP inhibitor use |
| Q33717573 | Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes |
| Q38103617 | Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology |
| Q86530584 | Expanding the functional repertoire of macrodomains |
| Q51887319 | Expression of antioxidant defense and poly(ADP-ribose) polymerase-1 in rat developing Sertoli cells. |
| Q37417939 | FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1 |
| Q27677345 | Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors |
| Q37522977 | Fluorescent sensors of PARP-1 structural dynamics and allosteric regulation in response to DNA damage |
| Q26865773 | Formation of nuclear heterochromatin: the nucleolar point of view |
| Q91972919 | Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase |
| Q46272600 | Frog (Pelophylax bergeri, Günther 1986) endocrine disruption assessment: characterization and role of skin poly(ADP-ribose) polymerases. |
| Q38811285 | Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress. |
| Q47624636 | Generation and Characterization of Recombinant Antibody-like ADP-Ribose Binding Proteins. |
| Q44187233 | Glucagon like-peptide-1 receptor is covalently modified by endogenous mono-ADP-ribosyltransferase |
| Q42448054 | Glucose deprivation converts poly(ADP-ribose) polymerase-1 hyperactivation into a transient energy-producing process |
| Q89008886 | Hepatocyte-Specific Deletion of TIPARP, a Negative Regulator of the Aryl Hydrocarbon Receptor, Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome |
| Q40432109 | High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer |
| Q36436390 | Identification and Functional Characterizations of N-Terminal α-N-Methylation and Phosphorylation of Serine 461 in Human Poly(ADP-ribose) Polymerase 3. |
| Q50898082 | Identification of ADP-Ribose Acceptor Sites on In Vitro Modified Proteins by Liquid Chromatography-Tandem Mass Spectrometry. |
| Q34129046 | Identification of a Regulatory Segment of Poly(ADP-ribose) Glycohydrolase |
| Q24318904 | Identification of candidate substrates for poly(ADP-ribose) polymerase-2 (PARP2) in the absence of DNA damage using high-density protein microarrays |
| Q31049613 | Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions |
| Q41910306 | Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs. |
| Q33652648 | Identifying Family-Member-Specific Targets of Mono-ARTDs by Using a Chemical Genetics Approach |
| Q42362081 | In vivo vizualisation of mono-ADP-ribosylation by dPARP16 upon amino-acid starvation |
| Q44516544 | Inhibition of ADP-ribosylation suppresses aberrant accumulation of lipidated apolipoprotein B in the endoplasmic reticulum |
| Q42009559 | Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool |
| Q28483989 | Inhibition of poly(ADP-ribose) polymerase interferes with Trypanosoma cruzi infection and proliferation of the parasite |
| Q38911909 | Inhibition of poly(adenosine diphosphate-ribose) polymerase using quinazolinone nucleus |
| Q46413178 | Insecticidal Toxin Complexes from Photorhabdus luminescens |
| Q34299288 | Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2. |
| Q50001563 | Insights into the biogenesis, function, and regulation of ADP-ribosylation. |
| Q64072077 | Interactions of p53 with poly(ADP-ribose) and DNA induce distinct changes in protein structure as revealed by ATR-FTIR spectroscopy |
| Q89581166 | Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family |
| Q26783018 | Intracellular Mono-ADP-Ribosylation in Signaling and Disease |
| Q41864162 | Investigation of the action of poly(ADP-ribose)-synthesising enzymes on NAD+ analogues |
| Q47109838 | Kinetics of poly(ADP-ribosyl)ation, but not PARP1 itself, determines the cell fate in response to DNA damage in vitro and in vivo |
| Q36150083 | Large-scale preparation and characterization of poly(ADP-ribose) and defined length polymers |
| Q36024949 | Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase |
| Q35860542 | Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality |
| Q34458110 | MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation |
| Q54250875 | Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious diseases. |
| Q45349630 | Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. |
| Q38111969 | Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation. |
| Q37956668 | Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1. |
| Q39220061 | Membrane-bound organelles versus membrane-less compartments and their control of anabolic pathways in Drosophila |
| Q37995716 | Metabolic sensors and their interplay with cell signalling and transcription. |
| Q33725941 | Method for the synthesis of mono-ADP-ribose conjugated peptides |
| Q30570945 | Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives |
| Q52316968 | Modulation of the secretory pathway by amino-acid starvation. |
| Q38880847 | Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection |
| Q42251960 | Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions |
| Q42700738 | Mono-ADP-ribosylation of histone 3 at arginine-117 promotes proliferation through its interaction with P300. |
| Q34234110 | Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers |
| Q34977358 | N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide |
| Q61796965 | NADP is an endogenous PARP inhibitor in DNA damage response and tumor suppression |
| Q27303843 | Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment |
| Q42507438 | New Quantitative Mass Spectrometry Approaches Reveal Different ADP-ribosylation Phases Dependent On the Levels of Oxidative Stress. |
| Q38810648 | New directions in poly(ADP-ribose) polymerase biology |
| Q34042969 | New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases |
| Q38020082 | New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs |
| Q92704594 | New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage |
| Q38024191 | New readers and interpretations of poly(ADP-ribosyl)ation |
| Q38229329 | Novel bacterial ADP-ribosylating toxins: structure and function |
| Q27304386 | Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review |
| Q89229576 | Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke |
| Q89581155 | Nuclear PARPs and genome integrity |
| Q55007528 | Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription. |
| Q41892525 | Nudix hydrolases degrade protein-conjugated ADP-ribose |
| Q38954348 | Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases |
| Q34802264 | Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair |
| Q39791288 | PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2 |
| Q89659933 | PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation |
| Q93341929 | PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification |
| Q38078993 | PARP inhibitors in cancer therapy: an update. |
| Q42095016 | PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain |
| Q37942024 | PARP-1 and PARP-2: New players in tumour development. |
| Q36703885 | PARP-1 inhibition influences the oxidative stress response of the human lens. |
| Q34421470 | PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells |
| Q64067890 | PARP-14 Promotes Survival of Mammalian α but Not β Pancreatic Cells Following Cytokine Treatment |
| Q34039475 | PARP-14 binds specific DNA sequences to promote Th2 cell gene expression |
| Q34503064 | PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation |
| Q33843139 | PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1. |
| Q24324178 | PARP-3 and APLF function together to accelerate nonhomologous end-joining |
| Q36454901 | PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis. |
| Q50277644 | PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation. |
| Q51758824 | PARP1 depletion induces RIG-I-dependent signaling in human cancer cells. |
| Q37701295 | PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage |
| Q42630324 | PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions. |
| Q47239029 | PARP10 (ARTD10) modulates mitochondrial function |
| Q54122586 | PARP10 suppresses tumor metastasis through regulation of Aurora A activity. |
| Q56354615 | PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins |
| Q42202315 | PARP12, an interferon-stimulated gene involved in the control of protein translation and inflammation. |
| Q24301867 | PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein response |
| Q24338323 | PARP16/ARTD15 is a novel endoplasmic-reticulum-associated mono-ADP-ribosyltransferase that interacts with, and modifies karyopherin-ß1 |
| Q39485255 | PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2B(Glu2) |
| Q36423470 | PARP6 is a Regulator of Hippocampal Dendritic Morphogenesis |
| Q36299937 | PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection |
| Q47833710 | PARPi potentiates with current conventional therapy in MLL leukemia |
| Q35769075 | PARPs and ADP-Ribosylation: 50 Years … and Counting |
| Q89581152 | PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis |
| Q37661664 | PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes |
| Q26859010 | PARPs and the DNA damage response |
| Q63246625 | PARPs in genome stability and signal transduction: implications for cancer therapy |
| Q37264322 | PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation |
| Q28080057 | Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP) |
| Q38306460 | Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl)ation sites from cells. |
| Q38984925 | Photorhabdus luminescens Toxins TccC3 and TccC5 Affect the Interaction of Actin with Actin-Binding Proteins Essential for Treadmilling |
| Q26858894 | Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation |
| Q90165209 | Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency |
| Q37607431 | Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity |
| Q90645966 | Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity |
| Q64085548 | Poly(ADP-Ribose) Polymerases in Plants and Their Human Counterparts: Parallels and Peculiarities |
| Q35860990 | Poly(ADP-Ribosyl)ation Affects Histone Acetylation and Transcription |
| Q99551282 | Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation |
| Q38134049 | Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications |
| Q24338495 | Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression |
| Q33578933 | Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling |
| Q38009733 | Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein |
| Q57788820 | Poly(ADP-ribose) polymerase-3 overexpression is associated with poor prognosis in patients with breast cancer following chemotherapy |
| Q37401119 | Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro. |
| Q41229337 | Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm. |
| Q39265687 | Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. |
| Q34159267 | Poly(ADP-ribose)-mediated interplay of XPA and PARP1 leads to reciprocal regulation of protein function. |
| Q40485657 | Poly(ADP-ribose): an organizer of cellular architecture |
| Q33636717 | Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function |
| Q64106238 | Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins |
| Q34786448 | Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription |
| Q35210105 | Poly(ADP-ribosyl)ation is required to modulate chromatin changes at c-MYC promoter during emergence from quiescence |
| Q90440149 | Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells |
| Q41535001 | Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development |
| Q36775024 | Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation |
| Q38846185 | Post-translational modifications in mitochondria: protein signaling in the powerhouse |
| Q38137764 | Predictive biomarkers for cancer therapy with PARP inhibitors. |
| Q83592540 | Profiling PARP inhibitors |
| Q36210493 | Protein ADP-Ribosylation Takes Control in Plant-Bacterium Interactions |
| Q37324094 | Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue. |
| Q48254511 | Proteomic Analysis of the Downstream Signaling Network of PARP1. |
| Q38255037 | Proteomics approaches to identify mono-(ADP-ribosyl)ated and poly(ADP-ribosyl)ated proteins. |
| Q40017593 | Proximal ADP-ribose Hydrolysis in Trypanosomatids is Catalyzed by a Macrodomain |
| Q37227952 | Quantification of cellular poly(ADP-ribosyl)ation by stable isotope dilution mass spectrometry reveals tissue- and drug-dependent stress response dynamics |
| Q33350327 | RCD1 and SRO1 are necessary to maintain meristematic fate in Arabidopsis thaliana |
| Q42011097 | RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD |
| Q36106467 | RNA damage in biological conflicts and the diversity of responding RNA repair systems |
| Q33685526 | Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts |
| Q38003341 | Rare and unusual glycosylation of peptides and proteins. |
| Q26775561 | Readers of poly(ADP-ribose): designed to be fit for purpose |
| Q42368008 | Redundancy between nucleases required for homologous recombination promotes PARP inhibitor resistance in the eukaryotic model organism Dictyostelium. |
| Q92620209 | Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation |
| Q24338265 | Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10 |
| Q47131999 | Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. |
| Q36204365 | Regulation of chromatin structure by poly(ADP-ribosyl)ation |
| Q38069879 | Reprogramming cellular events by poly(ADP-ribose)-binding proteins |
| Q64062654 | Research Progress on PARP14 as a Drug Target |
| Q64950221 | Reversible ADP-ribosylation of RNA. |
| Q39042927 | Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions |
| Q35006936 | SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress |
| Q26738332 | STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic Inflammation |
| Q28554210 | Sam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ation |
| Q35557026 | Scaffold hopping approach on the route to selective tankyrase inhibitors |
| Q34588927 | Sequence divergence and diversity suggests ongoing functional diversification of vertebrate NAD metabolism. |
| Q42318913 | Site-specific ADP-ribosylation of histone H2B in response to DNA double strand breaks. |
| Q36545280 | Site-specific noncovalent interaction of the biopolymer poly(ADP-ribose) with the Werner syndrome protein regulates protein functions. |
| Q64119168 | Solution NMR assignment of the ARC4 domain of human tankyrase 2 |
| Q47446139 | Specificity of reversible ADP-ribosylation and regulation of cellular processes. |
| Q24318798 | Spermatid head elongation with normal nuclear shaping requires ADP-ribosyltransferase PARP11 (ARTD11) in mice |
| Q37405386 | Structural Implications for Selective Targeting of PARPs |
| Q64057286 | Structural analyses of NudT16-ADP-ribose complexes direct rational design of mutants with improved processing of poly(ADP-ribosyl)ated proteins |
| Q42041151 | Structural and Biochemical Characterization of Poly-ADP-ribose Polymerase from Trypanosoma brucei |
| Q64086395 | Structural and biochemical evidence supporting poly ADP-ribosylation in the bacterium Deinococcus radiodurans |
| Q24299239 | Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease |
| Q29977768 | Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein |
| Q41986228 | Structural basis of autoinhibition and activation of the DNA-targeting ADP-ribosyltransferase pierisin-1. |
| Q38086332 | Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling |
| Q99571780 | Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases |
| Q27675133 | Structure Function Analysis of an ADP-ribosyltransferase Type III Effector and Its RNA-binding Target in Plant Immunity |
| Q27713797 | Structure of the sirtuin-linked macrodomain SAV0325 from Staphylococcus aureus |
| Q48140314 | Synthesis and Macrodomain Binding of Mono-ADP-Ribosylated Peptides |
| Q36379543 | Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells |
| Q89278597 | Synthetic α- and β-Ser-ADP-ribosylated Peptides Reveal α-Ser-ADPr as the Native Epimer |
| Q42365236 | Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling |
| Q38063790 | Tankyrase-targeted therapeutics: expanding opportunities in the PARP family |
| Q38104494 | Tankyrases as drug targets |
| Q38224266 | Tankyrases: structure, function and therapeutic implications in cancer |
| Q92604440 | Targeting ADP-ribosylation as an antimicrobial strategy |
| Q37996325 | Targeting bacterial toxins |
| Q89496376 | Targeting dePARylation for cancer therapy |
| Q37808971 | Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens |
| Q37138573 | The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response |
| Q36631422 | The Genomes of Three Uneven Siblings: Footprints of the Lifestyles of Three Trichoderma Species |
| Q47136688 | The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis. |
| Q58859255 | The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication |
| Q38872456 | The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival |
| Q37770152 | The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets |
| Q38993857 | The Promise of Proteomics for the Study of ADP-Ribosylation |
| Q37508170 | The Sound of Silence: RNAi in Poly (ADP-Ribose) Research |
| Q54279603 | The actin and Rho-modifying toxins PTC3 and PTC5 of Photorhabdus luminescens: enzyme characterization and induction of MAL/SRF-dependent transcription. |
| Q26991574 | The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs |
| Q40354602 | The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases |
| Q65000381 | The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression. |
| Q38402636 | The human NAD metabolome: Functions, metabolism and compartmentalization |
| Q89581157 | The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions |
| Q35207356 | The natural history of ADP-ribosyltransferases and the ADP-ribosylation system |
| Q38109700 | The recognition and removal of cellular poly(ADP-ribose) signals. |
| Q38473760 | The rise and fall of poly(ADP-ribose): An enzymatic perspective |
| Q89581163 | The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism |
| Q34029929 | The role of ADP-ribosylation in regulating DNA double-strand break repair |
| Q27727978 | The role of ADP-ribosylation in regulating DNA interstrand crosslink repair |
| Q38015737 | The role of PARP1 in the DNA damage response and its application in tumor therapy |
| Q27010084 | The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy |
| Q90566316 | The taming of PARP1 and its impact on NAD+ metabolism |
| Q37846088 | The ups and downs of tannins as inhibitors of poly(ADP-ribose)glycohydrolase. |
| Q90776650 | Tickling PARPs into serine action |
| Q26745673 | Trial watch - inhibiting PARP enzymes for anticancer therapy |
| Q41892598 | Tuning IL-2 signaling by ADP-ribosylation of CD25. |
| Q33875792 | Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). |
| Q41412881 | Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9. |
| Q28742180 | Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling |
| Q38946365 | VERO cells harbor a poly-ADP-ribose belt partnering their epithelial adhesion belt. |
| Q30413694 | Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy |
| Q47263675 | Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis. |
| Q35968729 | Virus-Host Interactions and the ARTD/PARP Family of Enzymes |
Search more.